FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

CONTOUR® NEXT GEN Blood Glucose Monitoring System

K Number: K223293 · Decision Nov 18, 2022
Classifications
1
FEI Numbers
168
Registration Numbers
169
Same Product Code
507
Applicant Total
7
Review Days
23

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
CONTOUR® NEXT GEN Blood Glucose Monitoring System
K Number
K223293
Device Class
FDA class 2
Clearance Type
Special
Regulation Number
862.1345
Medical Specialty
Clinical Chemistry
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Ascensia Diabetes Care U.S., Inc.
Date Received
October 26, 2022
Decision Date
November 18, 2022
Product Code
NBW
Advisory Committee
Clinical Chemistry
Review Advisory Committee
CH
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NBW System, Test, Blood Glucose, Over The Counter

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (NBW), ordered by most recent decision date.

View all

Other Clearances by Ascensia Diabetes Care U.S., Inc.

K Number Device Name
K250813 MICROLET®NEXT 2 Lancing Device
K241787 CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring System
K241810 MICROLET®NEXT Lancet
K220633 MICROLET NEXT lancing device, MICROLET Lancet
K162336 Contour Next EZ Blood Glucose Monitoring System
K160430 Contour Next Link Wireless Blood Glucose Monitoring System, Contour Next Blood Glucose Monitoring System